Renoscint (MAG3) is for diagnostic use only. After reconstitution and labelling with sodium (99mTc) pertechnetate solution, the diagnostic agent technetium (99mTc) tiatide may be used intravenously for the evaluation of nephrological and urological disorders in particular for the study of morphology, perfusion, and function of the kidney and characterisation of urinary outflow.

Danish Marketing Authorisation No.: 58417

For more detailed information regarding the product, such as the dosage and pharmacological properties, please refer to the Summary of Product Characteristics found below:

          Summary of Product Characteristics for RENOSCINT (MAG3)